SEC Form 4 · accession 0001652252-15-000035
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman D Schwartz
Officer — Chairman, President, and CEO · Director · 10% Owner
Period of report
Sep 10, 2015
Accepted (ET)
Sep 14, 2015 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad B Common StockF1 | Sep 10, 2015 | M | 2,000 | $0.00 | A | 195,308 | D | |
| Bio-Rad B Common StockF2 | Sep 10, 2015 | J | 1,058 | $0.00 | D | 194,250 | D | |
| Bio-Rad A Common StockF3 | Sep 11, 2015 | S | 1,058 | $137.3628 | D | 411,252 | D | |
| Bio-Rad B Common StockF1 | Sep 11, 2015 | M | 2,600 | $0.00 | A | 196,850 | D | |
| Bio-Rad B Common StockF2 | Sep 11, 2015 | J | 1,371 | $0.00 | D | 195,479 | D | |
| Bio-Rad A Common StockF3 | Sep 14, 2015 | S | 1,371 | $138.5006 | D | 411,252 | D | |
| Bio-Rad B Common StockF1 | Sep 12, 2015 | M | 2,617 | $0.00 | A | 198,096 | D | |
| Bio-Rad B Common StockF2 | Sep 12, 2015 | J | 1,380 | $0.00 | D | 196,716 | D | |
| Bio-Rad A Common StockF3 | Sep 14, 2015 | S | 1,380 | $138.4978 | D | 411,252 | D | |
| Bio-Rad B Common StockF4 | holding | — | — | — | 12,486 | I | By Spouse | |
| Bio-Rad B Common StockF5 | holding | — | — | — | 4,060,054 | I | By Blue Raven Partners, L.P. | |
| Bio-Rad B Common StockF6 | holding | — | — | — | 13,726 | I | By DANSA Partnership |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF7,F8 | $0.00 | Sep 10, 2015 | M | 2,000 | D | — | — | Bio-Rad B Common Stock | 2,000 | 8,000 | D |
| Restricted Stock UnitsF7,F9 | $0.00 | Sep 11, 2015 | A | 16,000 | A | — | — | Bio-Rad B Common Stock | 16,000 | 16,000 | D |
| Non-Qualified Stock Option (right to buy)F10 | $139.56 | Sep 11, 2015 | A | 16,000 | A | — | Sep 11, 2025 | Bio-Rad B Common Stock | 16,000 | 16,000 | D |
| Restricted Stock UnitsF7,F11 | $0.00 | Sep 11, 2015 | M | 2,600 | D | — | — | Bio-Rad B Common Stock | 2,600 | 7,800 | D |
| Restricted Stock UnitsF7,F12 | $0.00 | Sep 12, 2015 | M | 2,617 | D | — | — | Bio-Rad B Common Stock | 2,617 | 5,234 | D |
Explanation of responses
- F1Shares of Class B common stock acquired on the vesting of restricted stock units.
- F10The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
- F11The restricted stock units vest in five equal annual installments beginning September 11, 2014.
- F12The restricted stock units vest in five equal annual installments beginning September 12, 2013.
- F2The reporting person elected to convert shares of Class B common stock into Class A common stock on a 1-for-1 basis.
- F3Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
- F4The reporting person disclaims beneficial ownership of these shares.
- F5The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F6The shares are held by a limited partnership of which the reporting person is a limited partner.
- F7Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.
- F8The restricted stock units vest in five equal annual installments beginning September 10, 2015.
- F9The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.